BNP Paribas Financial Markets’s Aptose Biosciences, Inc. APTO Stock Holding History

BNP Paribas Financial Markets’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26	Closed	-$7.49K	–	4055
2023 Q1	$7.49K	Sell	26 -737	-97%	-$214K	﹤0.01%	3565
2022 Q4	$199K	Buy	763 +6	+0.8%	+$1.61K	﹤0.01%	2992
2022 Q3	$203K	Sell	757 -3	-0.4%	-$1.03K	﹤0.01%	3483
2022 Q2	$254K	Sell	760 -765	-50%	-$366K	﹤0.01%	2987
2022 Q1	$933K	Hold	1,525	–	–	﹤0.01%	2367
2021 Q4	$926K	Buy	1,525 +768	+101%	+$722K	﹤0.01%	2642
2021 Q3	$742K	Hold	757	–	–	﹤0.01%	2549
2021 Q2	$1.13M	Hold	757	–	–	﹤0.01%	2110
2021 Q1	$2.04M	Hold	757	–	–	﹤0.01%	1666
2020 Q4	$1.49M	Hold	757	–	–	﹤0.01%	1775
2020 Q3	$2.04M	Hold	757	–	–	﹤0.01%	1508
2020 Q2	$2.15M	Buy	757 +385	+103%	+$1.24M	﹤0.01%	1465
2020 Q1	$994K	Buy	+372	New	+$1.11M	﹤0.01%	1910

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets's APTO Position: Q2 2023 in Review

BNP Paribas Financial Markets sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 26 shares — an estimated $7.49K sold.

BNP Paribas Financial Markets first reported a position in APTO in Q1 2020 and held it in 13 quarters. The position peaked at $2.15M in Q2 2020. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

BNP Paribas Financial Markets reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
BNP Paribas Financial Markets sold 26 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $7.49K.
BNP Paribas Financial Markets first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 13 quarters.
BNP Paribas Financial Markets's Aptose Biosciences, Inc. position peaked at $2.15M in Q2 2020.
24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.